Understanding how immune modulation is impacted by different AhR ligands, their routes of administration, and their biodistribution is important for determining if AhR ligands may act as an environmental risk factor for T1D development, and/or how AhR can be exploited as a target for T1D treatment. The gene discussed is AHR; the disease is type 1 diabetes mellitus.